Finance

Beta
Lists
KLRA:NASDAQ
Kailera Therapeutics Inc
$19.37
-7.72%
(-1.62) 1D
Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KLRA...
Open
$21.17
High
$21.91
Low
$18.85
Mkt. cap
2.51B
Avg. vol.
610.67K
Volume
450.83K
52-wk high
$28.23
52-wk low
$18.85
EPS
-$1.20
No. of employees
145
Open
$21.17
High
$21.91
Low
$18.85
Mkt. cap
2.51B
Avg. vol.
610.67K
Volume
450.83K
52-wk high
$28.23
52-wk low
$18.85
EPS
-$1.20
No. of employees
145
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to KLRA in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for KLRA in the last 3 months.
Highest
Current $19.37
$48.00 (+147.81%)
Average
$39.00 (+101.34%)
Lowest
$30.00 (+54.88%)
News stories
From sources across the web
About Kailera Therapeutics Inc
CEO-
Employees145
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitekailera.com
Last report
Jun 25, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$3,650.00 / -$0.55
-664,987.46%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer